Sharp Daily
No Result
View All Result
Saturday, June 7, 2025
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
Sharp Daily
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team
No Result
View All Result
Sharp Daily
No Result
View All Result
Home News

World Bank commits KES 19.1 billion to Kenya’s vaccine production facility

Christine Akinyi by Christine Akinyi
February 9, 2024
in News
Reading Time: 2 mins read
world-bank

world-bank [Photo/Courtesy]

World Bank Vice President for Human Development Mamta Murthi has  announced a significant pledge of KES 19.1 billion to support the construction of Kenya’s long-awaited vaccine production facility.

This commitment signifies a pivotal advancement in Kenya’s pursuit of vaccine self-sufficiency and aims to reduce dependency on external sources.

The Kenya BioVax Institute is leading the development of this facility, slated to commence operations in 2029. With the backing of the World Bank, the facility is poised to become a cornerstone of Kenya’s healthcare infrastructure, playing a crucial role in locally packaging vaccines to bolster the nation’s health security.

The project will be executed in phases, with an initial focus on packaging and filling imported vaccines. The facility aims to release its first batch within the next five years to meet Kenya’s anticipated annual vaccine demand of 16 million doses, expected to rise to 25 million with population growth.

RELATEDPOSTS

World Bank: Kenya’s growth at risk from debt and poverty

May 26, 2025

Kenya engages World Bank to advance vaccine manufacturing

March 24, 2025

The ultimate objective is for the facility to transition to full-scale vaccine production, following models established in South Africa and Senegal. This transformation will enhance Kenya’s healthcare security and potentially position it as a regional vaccine supplier.

The World Bank’s financial commitment underscores the project’s critical significance, particularly as Kenya’s main vaccine donor, GAVI, plans to withdraw support in 2029. The BioVax facility is expected to bridge this gap and ensure continuous vaccine supply.

Health experts have previously expressed concerns about potential vaccine shortages post-GAVI’s exit. However, the World Bank’s intervention and the expedited development of the BioVax facility offer reassurance and pave the path for a sustainable vaccine supply chain in Kenya.

As Kenya embarks on this transformative journey towards vaccine production, collaboration among government entities, private sector stakeholders, and international partners will be essential.

With this substantial support from the World Bank, Kenya’s aspiration for vaccine self-sufficiency appears within reach. The project holds immense promise not only for strengthening the country’s healthcare system but also for establishing Kenya as a regional leader in vaccine production.

Previous Post

Pension contributors facing financial strain amid dwindling returns

Next Post

Bank of Japan set to leave negative interest rates

Christine Akinyi

Christine Akinyi

Related Posts

News

Co-op Bank posts KES 6.9 billion profit in Q1’2025

May 16, 2025
Agriculture And Economy
News

Lets get Kenya out of FATF list

May 9, 2025
News

The downside of Impact Investing

May 2, 2025
News

Leadership challenges at the University of Nairobi

April 24, 2025
News

Easter eggs and earnings: Growing your nest egg with CMMF

April 16, 2025
News

Geoffrey Ruku declares KES 377M net worth during CS vetting

April 15, 2025

LATEST STORIES

How Kenya’s E-Mobility shift could redefine urban planning

June 5, 2025

Economic liberators are the real heroes and heroines of the year

June 5, 2025

Affordable retirement planning for small businesses with CURBS

June 5, 2025

How Kenyan banks can modernize without marginalizing

June 4, 2025

Human rights concerns over activists’ treatment in Tanzania

June 4, 2025

Decoding stock-based compensation

June 4, 2025

Comparative advantage is the secret to real economic take off

June 4, 2025

Understanding inflation and its impact on everyday life

June 4, 2025
  • About Us
  • Meet The Team
  • Careers
  • Privacy Policy
  • Terms and Conditions
Email us: editor@thesharpdaily.com

Sharp Daily © 2024

No Result
View All Result
  • Home
  • News
    • Politics
  • Business
    • Banking
  • Investments
  • Technology
  • Startups
  • Real Estate
  • Features
  • Appointments
  • About Us
    • Meet The Team

Sharp Daily © 2024